Cardiovascular-metabolic impact of adiponectin and aquaporin

被引：0
|
作者：
Maeda, Norikazu [1 ]
Funahashi, Tohru [1 ,2 ]
Shimomura, Iichiro [1 ]
机构：
[1] Osaka Univ, Dept Metab Med, Grad Sch Med, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Dept Metab & Atherosclerosis, Grad Sch Med, Suita, Osaka 5650871, Japan
来源：
ENDOCRINE JOURNAL | 2013年 / 60卷 / 03期
关键词：
Adiponectin; Aquaporin; Adipocytes; Metabolic syndrome; Cardiovascular diseases; ACTIVATED-RECEPTOR-GAMMA; ADIPOSE-SPECIFIC PROTEIN; CORONARY-ARTERY-DISEASE; CHRONIC HEART-FAILURE; FATTY-ACID TRANSPORT; BREAST-CANCER RISK; PLASMA ADIPONECTIN; INSULIN-RESISTANCE; T-CADHERIN; ESSENTIAL-HYPERTENSION;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Visceral fat accumulation is located upstream of metabolic syndrome. Recent progress in adipocyte biology has clarified the molecular mechanism for pathophysiology of metabolic syndrome and its related disorders. In this review we summarize adiponectin and aquaporin 7 (AQP7) in the role of metabolic syndrome and cardiovascular diseases.
引用
收藏
页码：251 / 259
页数：9
相关论文
共 50 条
  • [1] Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases
    Matsuda, Morihiro
    Shimomura, Iichiro
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2014, 15 (01) : 1 - 10
  • [2] Cardiovascular significance of adipose-derived adiponectin and liver-derived xanthine oxidoreductase in metabolic syndrome
    Fujishima, Yuya
    Kita, Shunbun
    Nishizawa, Hitoshi
    Maeda, Norikazu
    Shimomura, Iichiro
    ENDOCRINE JOURNAL, 2023, 70 (07) : 663 - 675
  • [3] Adiponectin and metabolic cardiovascular diseases: Therapeutic opportunities and challenges
    Lei, Xiaotian
    Qiu, Sheng
    Yang, Gangyi
    Wu, Qinan
    GENES & DISEASES, 2023, 10 (04) : 1525 - 1536
  • [4] Update on therapeutic strategies to increase adiponectin function and secretion in metabolic syndrome
    Montecucco, F.
    Mach, F.
    DIABETES OBESITY & METABOLISM, 2009, 11 (05) : 445 - 454
  • [5] Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?
    Fisman, Enrique Z.
    Tenenbaum, Alexander
    CARDIOVASCULAR DIABETOLOGY, 2014, 13
  • [6] Adiponectin and the metabolic syndrome: mechanisms med ating risk for metabolic and cardiovascular disease
    Lara-Castro, Cristina
    Fu, Yuchang
    Chung, B. Hong
    Garvey, W. Timothy
    CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (03) : 263 - 270
  • [7] Adiponectin and Cardiovascular Disease
    Shibata, Rei
    Ouchi, Noriyuki
    Murohara, Toyoaki
    CIRCULATION JOURNAL, 2009, 73 (04) : 608 - 614
  • [8] Adiponectin: A potential therapeutic target for metabolic syndrome
    Ghadge, Abhijit A.
    Khaire, Amrita A.
    Kuvalekar, Aniket A.
    CYTOKINE & GROWTH FACTOR REVIEWS, 2018, 39 : 151 - 158
  • [9] Contentious role of 'Good Adiponectin' in pulmonary and cardiovascular diseases: Is adiponectin directed therapy a boon or a bane?
    Pathak, Manash Pratim
    Das, Aparoop
    Patowary, Pompy
    Chattopadhyay, Pronobesh
    BIOCHIMIE, 2020, 175 : 106 - 119
  • [10] The role of adiponectin in cardiovascular disease ?
    Peng, Jin
    Chen, Qian
    Wu, Chuncao
    CARDIOVASCULAR PATHOLOGY, 2023, 64
12345